In vivo growth-inhibition of Sarcoma 180 by an alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill.
Autoři: | Gonzaga ML; Department of Organic and Inorganic Chemistry, Federal University of Ceará, P.O. Box 12200, Fortaleza, Ceará, 60455-760, Brazil., Bezerra DP, Alves AP, de Alencar NM, Mesquita Rde O, Lima MW, Soares Sde A, Pessoa C, de Moraes MO, Costa-Lotufo LV |
---|---|
Zdroj: | Journal of natural medicines [J Nat Med] 2009 Jan; Vol. 63 (1), pp. 32-40. Date of Electronic Publication: 2008 Aug 23. |
Způsob vydávání: | Journal Article; Research Support, Non-U.S. Gov't |
Jazyk: | English |
Informace o časopise: | Publisher: Springer Country of Publication: Japan NLM ID: 101518405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0293 (Electronic) Linking ISSN: 13403443 NLM ISO Abbreviation: J Nat Med Subsets: MEDLINE |
Imprint Name(s): | Original Publication: Tokyo : Springer |
Výrazy ze slovníku MeSH: | Agaricus/*chemistry , Antineoplastic Agents/*pharmacology , Polysaccharides/*pharmacology , Sarcoma 180/*drug therapy, Animals ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/isolation & purification ; Cell Line ; Cell Line, Tumor ; Fungal Proteins/chemistry ; Glucans/chemistry ; Humans ; Male ; Mice ; Phytotherapy ; Polysaccharides/chemistry ; Polysaccharides/isolation & purification ; Sarcoma 180/pathology |
Abstrakt: | Agaricus blazei Murrill, a native mushroom of Brazil, has been widely consumed in different parts of the world due to its anticancer potential. This effect is generally attributed to its polysaccharides; however, the precise structure of these has not been fully characterized. To better understand the relationship between polysaccharide structures and antitumor activity, we investigated the effect of the intraperitoneally (i.p.) or orally (p.o.) administered alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide from A. blazei alone or in association with 5-fluorouracil (5-FU) in tumor growth using Sarcoma 180 transplanted mice. Hematological, biochemical, and histopathological analyses were performed in order to evaluate the toxicological aspects of the polysaccharide treatment. The polysaccharide had no direct cytotoxic action on tumor cells in vitro. However, the polysaccharide showed strong in vivo antitumor effect. Thus, the tumor growth-inhibitory effect of the polysaccharide is apparently due to host-mediated mechanisms. The histopathological analysis suggests that the liver and the kidney were not affected by polysaccharide treatment. Neither enzymatic activity of transaminases (AST and ALT) nor urea levels were significantly altered. In hematological analysis, leucopeny was observed after 5-FU treatment, but this effect was prevented when the treatment was associated with the polysaccharide. In conclusion, this polysaccharide probably could explain the ethnopharmacological use of this mushroom in the treatment of cancer. |
References: | Cancer Sci. 2004 Sep;95(9):758-64. (PMID: 15471563) Toxicol Appl Pharmacol. 2004 Dec 1;201(2):186-93. (PMID: 15541758) J Cancer Res Clin Oncol. 2005 Aug;131(8):527-38. (PMID: 15883813) Biotherapy. 1998;11(4):259-65. (PMID: 9950102) Mol Cell Biochem. 1998 Dec;189(1-2):113-8. (PMID: 9879661) J Appl Toxicol. 2008 Mar;28(2):156-63. (PMID: 17541943) Indian J Exp Biol. 1991 Jun;29(6):568-73. (PMID: 1889831) Cancer Immunol Immunother. 1998 May;46(3):147-59. (PMID: 9625538) Jpn J Pharmacol. 1994 Oct;66(2):265-71. (PMID: 7869611) Biosci Biotechnol Biochem. 1998 Mar;62(3):434-7. (PMID: 9571772) Cancer Sci. 2003 Feb;94(2):200-4. (PMID: 12708497) Carbohydr Res. 1989 Mar 15;186(2):267-73. (PMID: 2736561) Biol Pharm Bull. 2001 Jul;24(7):820-8. (PMID: 11456124) Chem Pharm Bull (Tokyo). 1986 May;34(5):2149-54. (PMID: 3742653) Cancer Chemother Pharmacol. 2001;47(1):11-4. (PMID: 11221954) Carbohydr Res. 1988 Nov 15;183(1):150-4. (PMID: 3233595) Exp Anim. 2003 Oct;52(5):371-5. (PMID: 14625400) Biochem Mol Biol Int. 1999 Apr;47(4):707-14. (PMID: 10319424) J Pharm Pharmacol. 2006 Feb;58(2):235-41. (PMID: 16451752) Braz J Med Biol Res. 2006 Jun;39(6):801-7. (PMID: 16751987) Expert Opin Drug Saf. 2005 Sep;4(5):915-28. (PMID: 16111453) Exp Biol Med (Maywood). 2004 May;229(5):393-406. (PMID: 15096651) J Immunol Methods. 1983 Dec 16;65(1-2):55-63. (PMID: 6606682) |
Substance Nomenclature: | 0 (Antineoplastic Agents) 0 (Fungal Proteins) 0 (Glucans) 0 (Polysaccharides) |
Entry Date(s): | Date Created: 20080830 Date Completed: 20090401 Latest Revision: 20211020 |
Update Code: | 20221213 |
DOI: | 10.1007/s11418-008-0286-4 |
PMID: | 18726068 |
Autor: | Gonzaga ML; Department of Organic and Inorganic Chemistry, Federal University of Ceará, P.O. Box 12200, Fortaleza, Ceará, 60455-760, Brazil., Bezerra DP, Alves AP, de Alencar NM, Mesquita Rde O, Lima MW, Soares Sde A, Pessoa C, de Moraes MO, Costa-Lotufo LV |
Jazyk: | angličtina |
Zdroj: | Journal of natural medicines [J Nat Med] 2009 Jan; Vol. 63 (1), pp. 32-40. Date of Electronic Publication: 2008 Aug 23. |
DOI: | 10.1007/s11418-008-0286-4 |
Abstrakt: | Agaricus blazei Murrill, a native mushroom of Brazil, has been widely consumed in different parts of the world due to its anticancer potential. This effect is generally attributed to its polysaccharides; however, the precise structure of these has not been fully characterized. To better understand the relationship between polysaccharide structures and antitumor activity, we investigated the effect of the intraperitoneally (i.p.) or orally (p.o.) administered alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide from A. blazei alone or in association with 5-fluorouracil (5-FU) in tumor growth using Sarcoma 180 transplanted mice. Hematological, biochemical, and histopathological analyses were performed in order to evaluate the toxicological aspects of the polysaccharide treatment. The polysaccharide had no direct cytotoxic action on tumor cells in vitro. However, the polysaccharide showed strong in vivo antitumor effect. Thus, the tumor growth-inhibitory effect of the polysaccharide is apparently due to host-mediated mechanisms. The histopathological analysis suggests that the liver and the kidney were not affected by polysaccharide treatment. Neither enzymatic activity of transaminases (AST and ALT) nor urea levels were significantly altered. In hematological analysis, leucopeny was observed after 5-FU treatment, but this effect was prevented when the treatment was associated with the polysaccharide. In conclusion, this polysaccharide probably could explain the ethnopharmacological use of this mushroom in the treatment of cancer. |
Databáze: | MEDLINE |
Externí odkaz: |